Search results

197 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Genetically-engineered preclinical models predict pharmacodynamic response
Preclinical testing a necessary step in drug development
Located in News / 2012 News
Parise and Leisner research into protein CIB1 profiled in Raleigh News and Observer
The Raleigh News and Observer interviewed Leslie Parise, PhD, professor and chair of the department of biochemistry, and Tina Leisner, PhD, a UNC research associate in biochemistry, about their research into the linkage between breast cancer and the protein CIB1.
Located in News / 2012 News
Robert Millikan, cancer researcher, gentle colleague, dies Oct. 7
A brilliant and beloved scientist has left us too early. Dr. Robert Millikan, Barbara Sorenson Hulka Distinguished Professor of Cancer Epidemiology, died Sunday, October 7. He was 55.
Located in News / 2012 News
Bae-Jump receives grant to study impact of obesity on ovarian cancer
Victoria Bae-Jump, MD, PhD, has received a two-year $200,000 grant from the Department of Defense, to study “Preclinical and Clinical Investigations of the Impact of Obesity on Ovarian Cancer Pathogenesis.”
Located in News / 2012 News
Amos quoted in ABC News feature
Keith Amos, MD, assistant professor of surgery at UNC-Chapel Hill, is quoted in an ABC News feature discussing a new study about partial breast removal surgery to treat cancer.
Located in News / 2012 News
UNC Lineberger honors five clinical fellows
UNC Lineberger honored five clinical fellows for their research accomplishments and clinical excellence.
Located in News / 2012 News
Der receives grant funding for pancreatic cancer research
Channing Der, PhD, Sarah Graham Kenan Professor of Pharmacology, received a two-year $200,000 American Association for Cancer Research Innovative grant from the Pancreatic Cancer Action Network. His grant will fund research on the mechanism of ERK inhibition resistance and ERK-dependent pancreatic cancer.
Located in News / 2012 News
Antibodies reverse Type 1 diabetes in new immunotherapy study
CHAPEL HILL, NC – Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease. Moreover, just two injections maintained disease remission indefinitely without harming the immune system.
Located in News / 2012 News
N.C. Children's Hospital achieves high rankings in several specialties including cancer
Congratulations to the N.C. Children’s Hospital for receiving top rankings in 10 out of 10 clinical categories in U.S. News & World Report’s 2012-13 “America’s Best Children’s Hospitals” list. The N.C. Children’s Hospital is ranked 26th in cancer.
Located in News / 2012 News
Sharpless, Zanation honored as Health Care Heroes
UNC Lineberger faculty members Ned Sharpless, MD, and Adam Zanation, MD, were honored for their achievements by Triangle Business Journal as 2012 Health Care Heroes.
Located in News / 2012 News